Mediterranean Diet Study, Type 1 Diabetes, Oxidative Stress
Summary
ClinicalTrials.gov registered a new observational/interventional study (NCT07544368) examining the effect of a 12-week Mediterranean diet on oxidative stress markers in girls aged 10-18 years with type 1 diabetes who do not meet the metabolic target (HbA1c > 7%). The study is planned between March 2026 and March 2027 and will be conducted at the Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University. Participants in the intervention group will receive Mediterranean diet adherence guidance and monitoring over the 12-week period.
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 676 changes logged to date.
What changed
NIH registered a clinical trial on ClinicalTrials.gov investigating whether a 12-week Mediterranean diet intervention reduces oxidative stress in pediatric type 1 diabetes patients with suboptimal glycemic control (HbA1c > 7%) and poor Mediterranean diet adherence. Participants were identified using the KIDMED pediatric Mediterranean diet adherence scale and HbA1c levels, with the intervention group (Group C) receiving dietary counseling over 12 weeks.
Healthcare providers and researchers conducting pediatric diabetes studies should note this registration reflects growing interest in nutritional interventions as adjunct therapies in type 1 diabetes management. The study's focus on metabolic target achievement and oxidative stress markers may inform future clinical guidance on medical nutrition therapy for this population.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MEDITERRANEAN DIET AND OXIDATIVE STRESS IN TYPE 1 DIABETES
N/A NCT07544368 Kind: NA Apr 22, 2026
Abstract
Achieving optimal glycemic control in type 1 diabetes requires a holistic approach that includes individualized medical nutrition therapy in addition to appropriate insulin therapy. When diabetes is poorly managed, metabolic control is impaired. Hyperglycemic events increase oxidative stress in the body and can lead to complications. The aim of this study is to examine the effect of a 12-week Mediterranean diet on oxidative stress markers in children with type 1 diabetes who do not meet the metabolic target (HbA1c > 7%) and whose adherence to the Mediterranean diet is "poor" and "needs improvement".
The study, planned between March 2026 and March 2027, will be conducted with girls aged 10-18 years with type 1 diabetes who are followed up at the Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University. In the first phase, participants were divided into groups based on their HbA1c levels: those with HbA1c ≤ 7 met the metabolic target (Group A); Those with HbA1c > 7 will be divided into two groups: those not meeting the metabolic target (Group B). In the second stage, the intervention group will be determined according to the results of the KIDMED, the pediatric Mediterranean diet adherence scale. Those in Group B who did not meet the metabolic targets and those with "poor" and "need improvement" KIDMED results will form the intervention group (Group C). Adolescents in Group C will receive a 12-week Mediterranean diet intervention. Informati...
Conditions: Type 1 Diabetes (Juvenile Onset), Continuous Glucose Monitoring System, Oxidative Stress
Interventions: Mediterranean Diet Intervention
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.